Overview

How Your Patients' Non-REM Sleep Changes On Sedatives in the Intensive Care Units

Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the effect of two standard of care sedative medications on sleep stages and total sleep time. The investigators hypothesize that the α2 agonist, dexmedetomidine, will improve sleep quality by increasing N2 and N3 sleep as well as total sleep time when compared to GABA agonists.
Phase:
Phase 1
Details
Lead Sponsor:
Vanderbilt University Medical Center
Treatments:
Dexmedetomidine
GABA Agonists
gamma-Aminobutyric Acid
Hypnotics and Sedatives
Lorazepam
Midazolam
Propofol